Kamijo, H.; Mochizuki, K.; Nakamura, Y.; Mori, K.; Ichikawa, M.; Nitta, K.; Imamura, H.
Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan. J. Clin. Med. 2020, 9, 2629.
https://doi.org/10.3390/jcm9082629
AMA Style
Kamijo H, Mochizuki K, Nakamura Y, Mori K, Ichikawa M, Nitta K, Imamura H.
Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan. Journal of Clinical Medicine. 2020; 9(8):2629.
https://doi.org/10.3390/jcm9082629
Chicago/Turabian Style
Kamijo, Hiroshi, Katsunori Mochizuki, Yuta Nakamura, Kotaro Mori, Michitaro Ichikawa, Kenichi Nitta, and Hiroshi Imamura.
2020. "Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan" Journal of Clinical Medicine 9, no. 8: 2629.
https://doi.org/10.3390/jcm9082629
APA Style
Kamijo, H., Mochizuki, K., Nakamura, Y., Mori, K., Ichikawa, M., Nitta, K., & Imamura, H.
(2020). Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan. Journal of Clinical Medicine, 9(8), 2629.
https://doi.org/10.3390/jcm9082629
